However, this strategy relies on pre-existing knowledge of the target
However, this strategy relies on pre-existing knowledge of the target. encouraging strategies for the development of malignancy therapies relies on monoclonal antibodies (mAbs). Tumor-specific mAbs… Read More »However, this strategy relies on pre-existing knowledge of the target